Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis
Géraldine Hipp, Michel Vaillant, Nico J. Diederich, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Update of the MDS research criteria for prodromal Parkinson's disease
Sebastian Heinzel, Daniela Berg, Thomas Gasser, et al.
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1464-1470
Open Access | Times Cited: 569
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Federico Baldini, Johannes Hertel, Estelle Sandt, et al.
BMC Biology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 184
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
Ayami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1448-1455
Open Access | Times Cited: 154
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Bastiaan R. Bloem, William J. Marks, Ana Lígia Silva de Lima, et al.
BMC Neurology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 101
Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease
Raja Mehanna, Katarzyna Śmiłowska, Jori Fleisher, et al.
Movement Disorders Clinical Practice (2022) Vol. 9, Iss. 7, pp. 869-878
Open Access | Times Cited: 61
Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism
Elisa Gómez de Lope, Rebecca Ting Jiin Loo, Armin Rauschenberger, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Progression subtypes in Parkinson’s disease identified by a data-driven multi cohort analysis
Tom Hähnel, Tamara Raschka, Stefano Sapienza, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Deep Phenotyping of Parkinson’s Disease
E. Ray Dorsey, Larsson Omberg, Emma Waddell, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 3, pp. 855-873
Open Access | Times Cited: 50
Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression
Fabian Kern, Tobias Fehlmann, Ivo Violich, et al.
Nature Aging (2021) Vol. 1, Iss. 3, pp. 309-322
Open Access | Times Cited: 41
Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females
Christophe Capelle, Séverine Ciré, Fanny Hedin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Cognition and Other Non-Motor Symptoms in an At-Risk Cohort for Parkinson’s Disease Defined by REM-Sleep Behavior Disorder and Hyposmia
Laure Pauly, Armin Rauschenberger, Claire Pauly, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 545-556
Open Access | Times Cited: 6
Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome
Matthias Klee, Velma T. E. Aho, Patrick May, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Open Access | Times Cited: 5
Management of Parkinson’s Disease 20 Years from Now: Towards Digital Health Pathways
Jochen Klucken, Rejko Krüger, Péter Schmidt, et al.
Journal of Parkinson s Disease (2018) Vol. 8, Iss. s1, pp. S85-S94
Open Access | Times Cited: 57
Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy
Lukas Pavelka, Armin Rauschenberger, Ahmed Abdelmonem Hemedan, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 4
Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson’s disease
Cyril Brzenczek, Quentin Klopfenstein, Tom Hähnel, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Bridging the Gap between Visual Assessments and Self-Reported Mobility in Geriatrics
A. G. Gómez Castro, Stefano Sapienza, Patricia Martins Conde, et al.
(2025)
Closed Access
Parkinson’s disease-associated alterations of the gut microbiome can invoke disease-relevant metabolic changes
Federico Baldini, Johannes Hertel, Estelle Sandt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 39
Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variation
Jochen Ohnmacht, Patrick May, Lasse Sinkkonen, et al.
Journal of Neural Transmission (2020) Vol. 127, Iss. 5, pp. 729-748
Open Access | Times Cited: 33
Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases
Valentina La Cognata, Giovanna Morello, Sebastiano Cavallaro
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4820-4820
Open Access | Times Cited: 29
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
Sinthuja Pachchek, Zied Landoulsi, Lukas Pavelka, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
The STRAT-PARK cohort: A personalized initiative to stratify Parkinson’s disease
Kjersti Eline Stige, Simon Ulvenes Kverneng, Soumya Sharma, et al.
Progress in Neurobiology (2024) Vol. 236, pp. 102603-102603
Open Access | Times Cited: 3
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
Andrea Sturchio, Luca Marsili, Joaquín A. Vizcarra, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 30
Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
Lukas Pavelka, Armin Rauschenberger, Zied Landoulsi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Body-First Subtype of Parkinson’s Disease with Probable REM-Sleep Behavior Disorder Is Associated with Non-Motor Dominant Phenotype
Lukas Pavelka, Armin Rauschenberger, Zied Landoulsi, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 8, pp. 2561-2573
Open Access | Times Cited: 17
Luxembourg Parkinson’s study -comprehensive baseline analysis of Parkinson’s disease and atypical parkinsonism
Lukas Pavelka, Rajesh Rawal, Soumyabrata Ghosh, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top